Physician

James Philip Davies, M.D.

According to 2025 Medicare claims, James Davies, M.D. (NPI: 1881034726) practices orthopedic surgery in the Tulsa, OK market, with the plurality of this provider's patient population coming from Tulsa, OK. This provider's primary affiliated billing organization is PREMIER ORTHOPEDIC SPECIALISTS OF TULSA (NPI: 1902349384; TIN: 81-4131585) and primary practice location at 74137-4212.

Davies' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 247 traditional Medicare patients, billed 2,021 HCPCS/CPT codes, and received $727,084 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 680 prescription claims across 195 beneficiaries totaling $5,076 in drug costs, led by Gabapentin (Gabapentin). DME data shows 33 claims. Open Payments data shows 35 records totaling $1,741. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $4,097 to $727,084. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $4,703 and ending at $5,076. For DME billing, reported payments fell sharply in recent years, from $12,760 to $2,796.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	28	83	$4,097
2020	137	627	$36,939
2021	186	897	$62,875
2022	209	1,644	$239,277
2023	246	1,718	$287,289
2024	247	2,021	$727,084

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	42	73	$4,703
2016	20	37	$3,808
2017	35	58	$1,538
2018	N/R	14	$68
2019	41	85	$2,805
2020	90	237	$12,215
2021	99	326	$5,302
2022	116	430	$5,058
2023	158	603	$6,047
2024	195	680	$5,076

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	27	$1,881
2021	16	36	$2,709
2022	47	87	$12,295
2023	15	15	$3,293
2024	13	33	$4,568

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	115	115	$110
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	161	287	$84
73610	X-ray of ankle, minimum of 3 views	87	140	$24
73630	X-ray of foot, minimum of 3 views	158	287	$23
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	42	171	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gabapentin	Gabapentin	122	2,910	$1,053
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	85	425	$917
Meloxicam	Meloxicam	212	6,761	$748
Ibuprofen	Ibuprofen	84	1,228	$462
Ondansetron Odt	Ondansetron	58	154	$369

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
L4361	Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated, off-the-shelf	N	13	13	$3,028
E0745	Neuromuscular stimulator, electronic shock unit	Y	N/R	20	$1,541

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	35	$1,741	Arthrex, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for James Philip Davies, M.D.?

Tedicare shows public-source Medicare data for James Philip Davies, M.D. (NPI 1881034726), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James Philip Davies, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to James Philip Davies, M.D.?

James Philip Davies, M.D. is linked to PREMIER ORTHOPEDIC SPECIALISTS OF TULSA (billing NPI 1902349384) in the available physician profile data.

Does James Philip Davies, M.D. have Open Payments data?

James Philip Davies, M.D. has 35 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.